SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Joe E. who wrote (3803)2/11/1998 12:47:00 PM
From: David S.  Read Replies (1) | Respond to of 6136
 
The physical stability of Vertex drug is a problem, and Vertex is late to the market with their PI - if somebody is doing OK with a regimen, why switch to a Vertex PI? especially since the newer data shows that switching is dangerous. of course, the newer data on switching is a mixed bag for Agouron also, and i don't have time to argue with the Agouron groupies. bye.